Nonnucleoside reverse transcriptase inhibitors reduce HIV-1 production from latently infected resting CD4+ T cells following latency reversal
Author(s):
Jennifer M. Zerbato, Gilda Tachedjian, Nicolas Sluis-Cremer
Details:
Antimicrobial Agents and Chemotherapy, Volume 61, Issue 3, 2017-03-01, Article number e01736
Article Link: Click here
Affiliations:
- Monash University
- University of Pittsburgh School of Medicine
- RMIT University
- Department of Microbiology & Immunology
- Burnet Institute